Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
38 1030 1508 0000 0008 1534 2003
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $925.2K$925,194 |
Buildings and premises | $23.6M$23,607,859 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 19, 2011 | Commercial Companies Code notice | |
| May 9, 2011 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 26, 2017 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $11,704$11,704 | Prezydent Miasta Kraków |
Tenders
No recorded participation in tenders.
Trademarks
Teva Operations Poland holds 76 active trademarks registered with the Polish Patent Office. 236 marks have expired or were not registered. The first mark was filed in 1969.
| Mark | Protected until | |
|---|---|---|
| FLEGAMINA FAST JUNIOR(word) | Oct 6, 2032 | |
| FLEGAMINA FAST(word) | Oct 6, 2032 | |
| METFORMAX COMBI(word) | Jan 21, 2032 | |
| SUPREMIN COMFORT(word) | Mar 23, 2030 | |
| SUPREMIN MAX(word) | Mar 23, 2030 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Pliva Hrvatska D.o.o. | 101 | $6,002,160.99 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2012-11-08 | Share capital change (22,000,000.00 PLN → 22,220,000.00 PLN) | |
| 2011-07-01 | Address change (Poleczki Budynek Platan Park Ii Wejście H 23, 02-822, Warszawa → Emilii Plater 53, 00-113, Warszawa) | |
| 2011-04-07 | Name change (Ratiopharm Polska → Teva Operations Poland) | |
| 2006-11-14 | Share capital change (17,000,000.00 PLN → 22,000,000.00 PLN) | |
| 2006-09-21 | Address change (Powsińska 4, 02-920, Warszawa → Poleczki Budynek Platan Park Ii Wejście H 23, 02-822, Warszawa) |
FAQ
Last updated: 2026-10-07